Yuen J, Hwang G, Fesler A, Intriago E, Pal A, Ojha A
Mol Ther Oncol. 2024; 32(1):200769.
PMID: 38596306
PMC: 10869788.
DOI: 10.1016/j.omton.2024.200769.
Indumati S, Apurva B, Gaurav G, Nehakumari S, Nishant V
J Reprod Infertil. 2023; 24(3):147-165.
PMID: 37663424
PMC: 10471942.
DOI: 10.18502/jri.v24i3.13271.
Dhandapani H, Bose M, Kesavan S
Asian Pac J Cancer Prev. 2022; 23(10):3347-3354.
PMID: 36308358
PMC: 9924325.
DOI: 10.31557/APJCP.2022.23.10.3347.
Klicka K, Grzywa T, Klinke A, Mielniczuk A, Wlodarski P
Cancers (Basel). 2021; 13(14).
PMID: 34298609
PMC: 8304659.
DOI: 10.3390/cancers13143393.
Favier A, Rocher G, Larsen A, Delangle R, Uzan C, Sabbah M
Cancers (Basel). 2021; 13(5).
PMID: 33800944
PMC: 7961497.
DOI: 10.3390/cancers13051137.
Bmi-1 Immunohistochemical Expression in Endometrial Carcinoma is Correlated with Prognostic Activity.
Horie K, Iseki C, Kikuchi M, Miyakawa K, Yoshizaki M, Yoshioka H
Medicina (Kaunas). 2020; 56(2).
PMID: 32059385
PMC: 7074093.
DOI: 10.3390/medicina56020072.
The Use of microRNAs in the Management of Endometrial Cancer: A Meta-Analysis.
Delangle R, De Foucher T, Larsen A, Sabbah M, Azais H, Bendifallah S
Cancers (Basel). 2019; 11(6).
PMID: 31208108
PMC: 6628044.
DOI: 10.3390/cancers11060832.
Inhibition of BMI1, a Therapeutic Approach in Endometrial Cancer.
Buechel M, Dey A, Dwivedi S, Crim A, Ding K, Zhang R
Mol Cancer Ther. 2018; 17(10):2136-2143.
PMID: 30026381
PMC: 7285980.
DOI: 10.1158/1535-7163.MCT-17-1192.
Identification of long non-coding RNAs biomarkers associated with progression of endometrial carcinoma and patient outcomes.
Sun Y, Zou X, He J, Mao Y
Oncotarget. 2017; 8(32):52604-52613.
PMID: 28881755
PMC: 5581054.
DOI: 10.18632/oncotarget.17537.
MicroRNAs in gynecological cancers: Small molecules with big implications.
Srivastava S, Ahmad A, Zubair H, Miree O, Singh S, Rocconi R
Cancer Lett. 2017; 407:123-138.
PMID: 28549791
PMC: 5601032.
DOI: 10.1016/j.canlet.2017.05.011.
Prognostic and Clinical Significance of miRNA-205 in Endometrioid Endometrial Cancer.
Wilczynski M, Danielska J, Dzieniecka M, Szymanska B, Wojciechowski M, Malinowski A
PLoS One. 2016; 11(10):e0164687.
PMID: 27737015
PMC: 5063284.
DOI: 10.1371/journal.pone.0164687.
miR-194 inhibits the proliferation, invasion, migration, and enhances the chemosensitivity of non-small cell lung cancer cells by targeting forkhead box A1 protein.
Zhu X, Li D, Yu F, Jia C, Xie J, Ma Y
Oncotarget. 2016; 7(11):13139-52.
PMID: 26909612
PMC: 4914347.
DOI: 10.18632/oncotarget.7545.
Regulation of epithelial-mesenchymal transition in endometrial cancer: connecting PI3K, estrogen signaling, and microRNAs.
Kent C, Guttilla Reed I
Clin Transl Oncol. 2016; 18(11):1056-1061.
PMID: 26856598
DOI: 10.1007/s12094-016-1492-2.
Polycomb complex protein BMI-1 promotes invasion and metastasis of pancreatic cancer stem cells by activating PI3K/AKT signaling, an ex vivo, in vitro, and in vivo study.
Wang M, Jiao M, Wu T, Jing L, Cui J, Guo H
Oncotarget. 2016; 7(8):9586-99.
PMID: 26840020
PMC: 4891062.
DOI: 10.18632/oncotarget.7078.
MicroRNAS in endometrial cancer: recent advances and potential clinical applications.
Yanokura M, Banno K, Iida M, Irie H, Umene K, Masuda K
EXCLI J. 2015; 14:190-8.
PMID: 26535032
PMC: 4614112.
DOI: 10.17179/excli2014-590.
Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review.
Huang Y, Yu J
World J Gastroenterol. 2015; 21(34):9863-86.
PMID: 26379393
PMC: 4566381.
DOI: 10.3748/wjg.v21.i34.9863.
Circulating levels of the miRNAs, miR-194, and miR-29b, as clinically useful biomarkers for colorectal cancer.
Basati G, Emami Razavi A, Pakzad I, Ali Malayeri F
Tumour Biol. 2015; 37(2):1781-8.
PMID: 26318304
DOI: 10.1007/s13277-015-3967-0.
MicroRNA-495 downregulates FOXC1 expression to suppress cell growth and migration in endometrial cancer.
Xu Y, Tian J, Hao Q, Yin L
Tumour Biol. 2015; 37(1):239-51.
PMID: 26198045
PMC: 4841847.
DOI: 10.1007/s13277-015-3686-6.
Small non-coding RNA deregulation in endometrial carcinogenesis.
Ravo M, Cordella A, Rinaldi A, Bruno G, Alexandrova E, Saggese P
Oncotarget. 2015; 6(7):4677-91.
PMID: 25686835
PMC: 4467107.
DOI: 10.18632/oncotarget.2911.
MicroRNA profiles following metformin treatment in a mouse model of non-alcoholic steatohepatitis.
Katsura A, Morishita A, Iwama H, Tani J, Sakamoto T, Tatsuta M
Int J Mol Med. 2015; 35(4):877-84.
PMID: 25672270
PMC: 4356452.
DOI: 10.3892/ijmm.2015.2092.